Collegium to Participate in Upcoming Investor Conferences
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
馬薩諸塞州斯托頓,2024年11月12日(環球新聞社) - Collegium Pharmaceutical, Inc.(納斯達克:COLL),一家領先的多元化特殊藥品公司,致力於改善與嚴重醫療條件患者的生活,今天宣佈管理層將參加以下投資者會議:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
傑富瑞倫敦醫療保健大會
爐邊聊天日期和時間:2024年11月19日星期二,格林威治標準時間下午1點30分
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
派傑投資第36屆醫療保健年會
爐邊聊天日期和時間:2024年12月5日星期四,美國東部時間下午1點
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: . A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
爐邊談話將通過公司網站的投資者部分進行網絡直播,並可從該公司的網站上進行訪問: 。網絡直播的重播將在演示結束後的90天內存檔在公司的網站上。
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at .
關於 Collegium Pharmaceutical, Inc.
Collegium是一家領先的多元化特殊藥品公司,致力於改善患有嚴重醫療狀況的人們的生活。 Collegium的總部位於馬薩諸塞州斯托頓。 欲了解更多信息,請訪問公司網站: 。
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
投資者聯繫人:
Danielle Jesse
投資者關係董事
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
媒體聯繫:
Marissa Samuels
企業通信副總裁
communications@collegiumpharma.com
譯文內容由第三人軟體翻譯。